The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matulonis, U.
Right arrow Articles by Griffin, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matulonis, U.
Right arrow Articles by Griffin, J. D.

The Journal of Immunology, Vol 156, Issue 3 1126-1131, Copyright © 1996 by American Association of Immunologists

ARTICLES

B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct

U Matulonis, C Dosiou, G Freeman, C Lamont, P Mauch, LM Nadler and JD Griffin
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Although intact, viable tumor cells rarely induce a clinically significant immune response in vivo, immunogenicity can be elicited by irradiated tumor cells that protect against subsequent challenge with wild-type intact viable tumor cells. Genetic modification of murine tumor cells, by transfection of cDNAs encoding either cytokines, MHC molecules, or costimulatory molecules, has been capable of inducing antitumor immunity. We and others have previously demonstrated that expression of the B7-1 costimulatory molecule, in either immunogenic or nonimmunogenic tumors, can protect against subsequent challenge with wild-type tumor cells. In this work, using a murine model of acute myeloid leukemia, we demonstrate that the B7-1 costimulatory molecule is superior to the B7-2 molecule in its capacity to protect against wild-type tumor challenge and eradicate minimal residual disease. These results provide compelling evidence that the B7-1 and B7-2 costimulatory signals are functionally distinct, thus resulting in clinically significant differences in the induction of antitumor immunity in vivo.


This article has been cited by other articles:


Home page
 ChestHome page
X.-D. Liang, H.-Z. Shi, X.-J. Qin, and J.-M. Deng
Increase in Concentration of Soluble CD86 After Segmental Allergen Challenge in Patients With Allergic Asthma.
Chest, October 1, 2006; 130(4): 1048 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Pejawar-Gaddy and M. A. Alexander-Miller
Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes
J. Immunol., October 1, 2006; 177(7): 4495 - 4502.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Arimilli, M. A. Alexander-Miller, and G. D. Parks
A Simian Virus 5 (SV5) P/V Mutant Is Less Cytopathic than Wild-Type SV5 in Human Dendritic Cells and Is a More Effective Activator of Dendritic Cell Maturation and Function.
J. Virol., April 1, 2006; 80(7): 3416 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X.-T. Ma, B. Xu, L.-L. An, C.-Y. Dong, Y.-M. Lin, Y. Shi, and K.-F. Wu
Vaccine with {beta}-Defensin 2-Transduced Leukemic Cells Activates Innate and Adaptive Immunity to Elicit Potent Antileukemia Responses
Cancer Res., January 15, 2006; 66(2): 1169 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
K. Kronfeld, E. Hochleitner, S. Mendler, J. Goldschmidt, R. Lichtenfels, F. Lottspeich, H. Abken, and B. Seliger
B7/CD28 Costimulation of T Cells Induces a Distinct Proteome Pattern
Mol. Cell. Proteomics, December 1, 2005; 4(12): 1876 - 1887.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. S. Pejawar, G. D. Parks, and M. A. Alexander-Miller
Abortive versus Productive Viral Infection of Dendritic Cells with a Paramyxovirus Results in Differential Upregulation of Select Costimulatory Molecules
J. Virol., June 15, 2005; 79(12): 7544 - 7557.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H-Z Shi, Z-F Xie, J-M Deng, Y-Q Chen, and C-Q Xiao
Soluble CD86 protein in serum samples of patients with asthma
Thorax, October 1, 2004; 59(10): 870 - 875.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Caldwell, A. Heitger, W. Shen, Y. Liu, B. Taylor, and S. Ladisch
Mechanisms of Ganglioside Inhibition of APC Function
J. Immunol., August 15, 2003; 171(4): 1676 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
C. Vasu, A. Wang, S. R. Gorla, S. Kaithamana, B. S. Prabhakar, and M. J. Holterman
CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties
Int. Immunol., February 1, 2003; 15(2): 167 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter
Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice
Infect. Immun., December 1, 2002; 70(12): 6940 - 6947.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Mohty, D. Isnardon, A. Charbonnier, M. Lafage-Pochitaloff, M. Merlin, D. Sainty, D. Olive, and B. Gaugler
Generation of potent Th1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells
Int. Immunol., July 1, 2002; 14(7): 741 - 750.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. LaBelle, C. A. Hanke, B. R. Blazar, and R. L. Truitt
Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia
Blood, March 15, 2002; 99(6): 2146 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Mohty, D. Jarrossay, M. Lafage-Pochitaloff, C. Zandotti, F. Briere, X.-N. de Lamballeri, D. Isnardon, D. Sainty, D. Olive, and B. Gaugler
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
Blood, December 15, 2001; 98(13): 3750 - 3756.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
J. Immunol., November 1, 2001; 167(9): 5386 - 5394.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Ghia, P. Transidico, J. P. Veiga, C. Schaniel, F. Sallusto, K. Matsushima, S. E. Sallan, A. G. Rolink, A. Mantovani, L. M. Nadler, et al.
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells
Blood, August 1, 2001; 98(3): 533 - 540.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Notter, T. Willinger, U. Erben, and E. Thiel
Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells
Blood, May 15, 2001; 97(10): 3138 - 3145.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Santra, D. H. Barouch, S. S. Jackson, M. J. Kuroda, J. E. Schmitz, M. A. Lifton, A. H. Sharpe, and N. L. Letvin
Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL Responses
J. Immunol., December 15, 2000; 165(12): 6791 - 6795.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Pope, R. D. Brown, J. Gibson, E. Yuen, and D. Joshua
B7-2-positive myeloma: incidence, clinical characteristics, prognostic significance, and implications for tumor immunotherapy
Blood, August 15, 2000; 96(4): 1274 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Stripecke, A. A. Cardoso, K. A. Pepper, D. C. Skelton, X.-J. Yu, L. Mascarenhas, K. I. Weinberg, L. M. Nadler, and D. B. Kohn
Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses
Blood, August 15, 2000; 96(4): 1317 - 1326.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Müerköster, J. D. Laman, M. Rocha, V. Umansky, and V. Schirrmacher
Functional and in Situ Evidence for Nitric Oxide Production Driven by CD40-CD40L Interactions in Graft-versus-Leukemia Reactivity
Clin. Cancer Res., May 1, 2000; 6(5): 1988 - 1996.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. Martin-Fontecha, M. Moro, M. C. Crosti, F. Veglia, G. Casorati, and P. Dellabona
Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity
J. Immunol., January 15, 2000; 164(2): 698 - 704.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Dunussi-Joannopoulos, K. Runyon, J. Erickson, R. G. Schaub, R. G. Hawley, and J. P. Leonard
Vaccines With Interleukin-12-Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity
Blood, December 15, 1999; 94(12): 4263 - 4273.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Cignetti, E. Bryant, B. Allione, A. Vitale, R. Foa, and M.A. Cheever
CD34+ Acute Myeloid and Lymphoid Leukemic Blasts Can Be Induced to Differentiate Into Dendritic Cells
Blood, September 15, 1999; 94(6): 2048 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Moro, A. M. Gasparri, S. Pagano, M. Bellone, P. Tornaghi, F. Veglia, A. Corti, G. Casorati, and P. Dellabona
Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules
Cancer Res., June 1, 1999; 59(11): 2650 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. K. Martin, J. G. Frelinger, and J. P.-Y. Ting
Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth
J. Immunol., June 1, 1999; 162(11): 6663 - 6670.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. N. L. Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr
Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism
J. Immunol., April 15, 1999; 162(8): 4817 - 4823.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B.-a. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein
4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine
J. Immunol., April 15, 1999; 162(8): 5003 - 5010.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. Stremmel, E.A. Greenfield, E. Howard, G.J. Freeman, and V.K. Kuchroo
B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4-dependent Mechanism
J. Exp. Med., March 15, 1999; 189(6): 919 - 930.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H.-G. Fischer, R. Dorfler, B. Schade, and U. Hadding
Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice
Int. Immunol., March 1, 1999; 11(3): 341 - 349.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Slavik, J. E. Hutchcroft, and B. E. Bierer
CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28
J. Biol. Chem., January 29, 1999; 274(5): 3116 - 3124.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. N. La Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr
Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells
J. Immunol., December 15, 1998; 161(12): 6552 - 6558.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. E. Fields, R. J. Finch, G. S. Gray, R. Zollner, J. L. Thomas, K. Sturmhoefel, K. Lee, S. Wolf, T. F. Gajewski, and F. W. Fitch
B7.1 Is a Quantitatively Stronger Costimulus Than B7.2 in the Activation of Naive CD8+ TCR-Transgenic T Cells
J. Immunol., November 15, 1998; 161(10): 5268 - 5275.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Mutis, E. Schrama, C. J.M. Melief, and E. Goulmy
CD80-Transfected Acute Myeloid Leukemia Cells Induce Primary Allogeneic T-Cell Responses Directed at Patient Specific Minor Histocompatibility Antigens and Leukemia-Associated Antigens
Blood, September 1, 1998; 92(5): 1677 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. M. Challita-Eid, M. L. Penichet, S.-U. Shin, T. Poles, N. Mosammaparast, K. Mahmood, D. J. Slamon, S. L. Morrison, and J. D. Rosenblatt
A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway
J. Immunol., April 1, 1998; 160(7): 3419 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Dunussi-Joannopoulos, G. Dranoff, H. J. Weinstein, J. L.M. Ferrara, B. E. Bierer, and J. M. Croop
Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines
Blood, January 1, 1998; 91(1): 222 - 230.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. W. Boyer, D. A. Vallera, P. A. Taylor, G. S. Gray, E. Katsanis, K. Gorden, P. J. Orchard, and B. R. Blazar
The Role of B7 Costimulation by Murine Acute Myeloid Leukemia in the Generation and Function of a CD8+ T-Cell Line With Potent In Vivo Graft-Versus-Leukemia Properties
Blood, May 1, 1997; 89(9): 3477 - 3485.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.